Helicon Health is delighted to announce that Sander ten Veldhuijs, Director of Operations, has joined the NHS Innovation Accelerator programme.
“We congratulate Sander on this massive achievement and wish him every success in this initiative over the next three years.”
Professor David Patterson, Founder of Helicon Health
Each NIA Fellow and their innovation are selected through a robust, multi-stage application and assessment process involving an expert panel of clinical, patient and commercial assessors.
The NIA will help Sander and the Helicon Health team focus on accelerating the Hailie® Digital Inhaler, a bluetooth-based medication adherence solution. Hailie® uses sensors that fit onto regular inhalers to offer real-time feedback to patients via the Hailie® app and to Clinicians via secure web portal. Hailie®is used extensively by Helicon Health to implement Virtual Ward and remote patient monitoring and digital therapeutic solutions.
Sander joins a cohort of seventeen new Fellows joining the NHS Innovation Accelerator programme in 2023. This is the largest cohort for the programme since its launch in 2015.
Each NIA Fellow and their innovation are selected through a robust, multi-stage application and assessment process involving an expert panel of clinical, patient and commercial assessors.
The NIA is an award-winning NHS England initiative, working to support NHS Long Term Plan priorities by accelerating uptake of promising innovations for patient, population and NHS staff benefit. It is commissioned by the NHS Accelerated Access Collaborative, hosted by UCLPartners and delivered in partnership with the 15 Academic Health Science Networks (AHSNs).
More infomation can be found in the Fellows Brochure.
